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Series of N'-(pyridine-3-ylmethylene)benzohydrazides 3a-y have been prepared by the condensation of nicotinaldehydes 
1a-e with benzohydrazides 2a-e in the presence of glacial AcOH in ethanol at room temperature. Total twenty five 
compounds have been prepared and confirmed based on spectral data. The compounds have been evaluated for anti-
microbial, free radical scavenging (DPPH, ABTS.+) and α-glucosidase inhibitory activities. Compound 3h has shown potent 
anti-fungal activity. Compounds 3f-g and 3j have shown potent ABTS.+ free radical scavenging activity. Compound 3d has 
shown potent anti-hyperglycemic activity. 
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Chloronicotinaldehydes are the important heterocyclic 
compounds and have potential applications in the 
areas of pharmaceutical and agrochemicals
1-6
. Pyridine 
heterocyclic compounds have been achieved through 
C-C bond forming reactions such as Sonogashira7 and 
Suzuki-Miyaura coupling reactions
8
 by replacing the 
chloro group of the pyridine positioned at C-2. The 
replacement of chlorine with N-, O-, and S-containing 
nucleophiles also provides the novel heterocyclic 
compounds9. 2-Chloropyridine containing bio-active 
heterocyclic compounds
10-12
 such as 1,3,4-oxadiazoles, 
flavones and dihydropyrazoles are well reported in the 
literature. 
Benzohydrazides and their derivatives are promising 
organic compounds bearing -CO, –NH and –NH2 
functionalities
13-15
. Benzohydrazides have important 
applications in pharmaceutical and analytical chemistry
16,17
. 
Heterocyclic compounds with benzohydrazide moiety 
have displayed various biological activities
18,19
 such 
as anti-leishmanial, anti-inflammatory, anti-cancer, 
anti-mycobacterial and anti-tumor. 
As part of our ongoing research on 2-
chloronicotinaldehydes, we have reported useful 
heterocyclcic compounds
20-23
. Recently, we have 
shown 2H-chromenylmethylene benzohydrazides as 
potential anti-microbial agents
24
. The present manuscript 
describes the preparation of N'-(pyridin-3-ylmethylene) 
benzohydrazides and biological screening of anti-
microbial, free radical scavenging (DPPH, ABTS
.+
) 
and α-glucosidase inhibitory activities. 
 
Results and Discussion 
The preparation of N'-(pyridin-3-ylmethylene) 
benzohydrazides 3a-e depicted in Scheme I. In an  
initial experiment, we have chosen nicotinaldehyde  
1a as the starting substrate to prepare the target 
compound. Nicotinaldehyde 1a (1.0 equiv.) was stirred 
with benzohydrazide 2a (1.0 equiv.) in glacial AcOH 
(0.2 mL) in ethyl alcohol (2 mL) at RT. The reaction 
proceeded smoothly and provided N'-(pyridin-3-
ylmethylene)benzohydrazide 3a as colourless solid in 
91% yield. This result was encouraged us to carry out 
the reaction of 1a with substituted benzohydrizides 2b-d 
and Isoniazid 2e under above reaction conditions. All 
these reactions proceeded smoothly and provided the 
target compounds 3b-j (Table I). All the compounds are 
unknown and characterized by spectral data (see SI). 
Having achieved N-pyridinylmethylene benzohydrazides 
3a-j and then we have planned to prepare the required 
starting materials to make another set of target 




compounds. The starting materials were prepared by 
replacing the chloro group with moieties such as 
piperidine 1c, morpholine 1d and thio-morpholine 1e as 
per the Scheme II. 2-Chloronicotinaldehyde 1b was 
reacted with 1c-e in the presence of K2CO3 in dry DMF 
at 90°C and furnished the corresponding nicotinaldehydes 
1c-e. 
Scheme III describes the preparation of target 
compounds N'-((2-substituted pyridinyl)methylene) 
benzohydrazides 3k-y. Nicotinaldehydes 1c-e (1.0 
equiv.) were stirred with benzohydrazides 2a-e (1.0 
equiv.) in the presence of glacial AcOH (0.2 mL) in 
ethyl alcohol (2 mL) at RT. All these reactions 
underwent smoothly and provided the target compounds 
3k-y (Table I). All the prepared compounds 3a-y are 
unknown and characterized by spectral data (see SI). 
 
Biology 
Thus prepared compounds 3a-y were tested for 
anti-microbial, free radical scavenging (DPPH, ABTS
.+
) 
and anti-hyperglycaemic (rat intestinal α-glucosidase) 
activities
25,26





Table I — Preparation of N-(pyridin-3-ylmethylene)benzohydrazides 3a-y a 
Entry Compd X Z R 
1 3a H C H 
2 3b H C 4-OCH3 
3 3c H C 3,4,5-OCH3 
4 3d H C 4-F 
5 3e H N H 
6 3f Cl C H 
7 3g Cl C 4-OCH3 
8 3h Cl C 3,4,5-OCH3 
9 3i Cl C 4-F 
10 3j Cl N H 
11 3k 2-Piperidininyl C H 
12 3l 2-Piperidininyl C 4-OCH3 
13 3m 2-Piperidininyl C 3,4,5-OCH3 
14 3n 2-Piperidininyl C 4-F 
15 3o 2-Piperidininyl N H 
16 3p 2-Morpholinyl C H 
17 3q 2-Morpholinyl C 4-OCH3 
18 3r 2-Morpholinyl C 3,4,5-OCH3 
19 3s 2-Morpholinyl C 4-F 
20 3t 2-Morpholinyl N H 
21 3u 2-Thio-morpholinyl C H 
22 3v 2-Thio-morpholinyl C 4-OCH3 
23 3w 2-Thio-morpholinyl C 3,4,5-OCH3 
24 3x 2-Thio-morpholinyl C 4-F 
25 3y 2-Thio-morpholinyl N H 
 a Isolated yields 
 





The anti-microbial activity of compounds 3a-y tested 
against two Gram-positive organisms (Bacillus subtilis; 
Staphylococcus epidermis) and two Gram-negative 
organisms (Pseudomonas aeruginosa; Escherichia coli) 
by agar well diffusion method and compared with the 
Streptomycin. The compounds data and zone of 
inhibition (mm) values were presented in Table II
 25
. 
Analysis of anti-bacterial potential of the tested 
compounds revealed that total twelve compounds have 
been displayed activity against tested gram positive and 
three compounds displayed against tested gram negative 
bacterial strains. 
The compounds 3a, 3k-l and 3u-x have shown the 
moderate anti-bacterial activity against B. subtilis and 
compounds 3b, 3f-g, 3n and 3v displayed moderate 
activity against S. epidermis. The compounds 3e, 3h 
and 3p have shown moderate anti-bacterial activity 
against E. coli. The structure activity relationship of 
the compounds revealed that the compounds 3a, 3v 
(methoxy group present on benzohydrazide with thio-
morpholine on pyridyl) and 3x (fluoro group present 
on benzohydrazide with thio-morpholine on pyridyl) 
have shown moderate activity against B. subtilis. The 
compounds 3f are having chloro substitution on 
pyridyl and compound 3g having additional methoxy 
substitution present on phenyl shown the moderate 
activity against S. epidermis. The compound having 
fluoro group present on phenylhydrazide and 
piperidine substitution at 2
nd
 position on pyridyl 3n 
(10 mm) displayed better anti-bacterial activity 
against S. epidermis when compared to compound 3i 
having chloro substitution. 
The anti-fungal activities of the target compounds  
3a-y were tested against Candida albicans  
and fluconazole was used as standard drug (Table II). 
The compounds 3h has shown potent and 3i, 3p and  
3v have shown moderate anti-fungal activity.  
The structure activity relationship of the compounds 
revealed that the compounds 3h having trimethoxy 
group present on benzohydrazide with chloro on  
pyridyl have shown potent activity when compared to 
mono methoxy compound 3g. The compound 3p was 
having morpholine substitution on pyridyl and 
compound 3v having thio-morpholine present on pyridyl 





 free radical scavenging activity 





 of target compounds 3a-y along with the 
standard drugs are presented in Table III. None of the 
compounds displayed DPPH free radical scavenging 
activity. Interestingly, compounds 3f-g (SC50 1.32, 
1.35 µg /mL) and 3j (SC50 1.54 µg /mL) have shown 
potent and significant ABTS
.+
 free radical scavenging 
activity in present series of compounds in comparison 














Table III represents the anti-hyperglycaemic (rat 
intestinal α-glucosidase) activity26 and their IC50 
values of target compounds 3a-y along with the 
standard drug Acarbose. Only one compound 3d (IC50 
3.02 µg/mL) having fluoro substitution present on 
benzohydrazide moiety displayed potent anti-
hyperglycemic activity in comparison with Acarbose 
(IC50 2.69 µg/mL). 
 
Experimental Section 
All the chemicals and reagents were purchased 
from Aldrich (Sigma-Aldrich, USA), AVRA 
Chemicals Pvt. Ltd (Hyderabad, India) and were used 
without further purification. Reactions were 
monitored by thin layer chromatography (TLC) on 
pre-coated silica gel 60 F254 (mesh); spots were 
visualized under UV light. Melting points were 
determined on a Stuart melting point apparatus and 
are uncorrected. IR spectrum was recorded with a 




C NMR spectra were recorded on Bruker Avance 
300, 400 and 500 MHz spectrometers. Chemical shifts 
(δ) are quoted in parts per million and are referenced 
to tetramethylsilane (TMS) as internal standard. ESI-
MS obtained on Quarto Micro spectrometer. 
 
General experimental procedure for the preparation 
of (E)-N'-(pyridin-3-ylmethylene) benzohydrazides, 
3a-y 
Glacial acetic acid (0.2 mL) was added to a stirred 
solution of nicotinaldehyde 1a (1.0 mmol), 
benzohydrazide 2a (1.0 mmol) in absolute ethanol  
(3 mL) at RT and the contents were stirred at the same 
Table II — Anti-microbial activity profile of compounds 3a-y 
 Anti-bacterial Anti-fungal 
 Gram-positive Gram-negative  
Compd B. subtilis S. epidermidis P. aeruginosa E. coli C. albicans 
3a 7 − − − − 
3b − 6 − − − 
3c − − − − − 
3d − − − − − 
3e − − − 6 − 
3f − 7 − − − 
3g − 7 − 6 − 
3h − − − − 18 
3i − − − − 6 
3j − − − − − 
3k 5 − − − − 
3l 6 − − − − 
3m − − − − − 
3n − 10 − − − 
3o − − − − − 
3p − − − 7 9 
3q − − − − − 
3r − − − − − 
3s − − − − − 
3t − − − − − 
3u 5 − − − − 
3v 8 7 − − 8 
3w 6 − − − − 
3x 7 − − − − 
3y − − − − − 
Control 0 0 0 0 0 
Streptomyci
n 
19 13 13 16 − 
Fluconazole − − − − 22 (0.12, 0.25) 
B. subtilis: Bacillus subtilis, S. epidermidis: Staphylococcus epidermidis, P. aeruginosa: Pseudomonas aeruginosa, E. coli: Escherichia 
coli, C. albicans: Candida albicans. The presented values represent the zone of inhibition in millimeter (mm) on agar plate against the 
represented microbial strains.  
 




temperature. After completion of the reaction (TLC, 1 
h), the reaction mixture was filtered through 
Whatman filter paper and compound was 
recrystallized from ethanol to afford (E)-N'-(pyridin-
3-ylmethylene)benzohydrazide 3a as colourless solid. 
The compounds 3b-y were prepared by the reaction of 
nicotinaldehydes 1a-b with benzohydrazides 2a-e 
under above conditions. All the prepare compounds 
are unknown and well characterized by spectral data. 
(E)-N'-(Pyridin-3-ylmethylene)benzohydrazide, 
3a: Yield 91%. Colourless solid. m.p. 192-194°C. FT-





H NMR (400 MHz, DMSO-d6): δ 12.03 
(s, 1H), 8.87 (s, 1H), 8.62 (d, J = 3.8 Hz, 1H), 8.52  
(s, 1H), 8.16 (d, J = 7.8 Hz, 1H), 7.93 (d, J = 7.4 Hz, 
2H), 7.76-7.24 (m, 4H);
 13
C NMR (101 MHz, DMSO-
d6): δ 163.74, 151.19, 149.21, 145.53, 133.98, 133.71, 





benzohydrazide, 3b: Yield 90%. Colourless solid. 
m.p. 165-167°C. FT-IR (KBr): 3187, 3008, 1667, 





(400 MHz, DMSO-d6): δ 11.90 (s, 1H), 8.85 (s, 1H), 
8.61 (dd, J = 4.6, 1.2 Hz, 1H), 8.51 (s, 1H), 8.14 (d,  
J = 6.7 Hz, 1H), 7.93 (d, J = 8.8 Hz, 2H), 7.49 (dd,  
J = 7.8, 4.8 Hz, 1H), 7.08 (d, J = 8.8 Hz, 2H), 3.85 (s, 
3H); 
13
C NMR (101 MHz, DMSO-d6): δ 163.11, 
162.60, 151.05, 149.13, 144.86, 133.84, 130.85, 





benzohydrazide, 3c: Yield 89%. Colourless solid. 
m.p. 172-174°C. FT-IR (KBr): 3455, 3198, 2939, 




H NMR (400 MHz, DMSO-d6): δ 11.88 (s, 1H), 8.87 
(s, 1H), 8.63 (d, J = 3.8 Hz, 1H), 8.53 (s, 1H), 8.16 (d, 
J = 7.8 Hz, 1H), 7.50 (dd, J = 7.8, 4.8 Hz, 1H), 7.25 (s, 
Table III — DPPH, ABTS.+ and α-Glucosidase inhibitory activity profile of compounds 3a-y 
Compd 
DPPH % Inhibition 25 µg/mL 
(SC50 µg /mL) 
ABTS.+ % Inhibition 
20 µg /mL (SC50 µg /mL) 
α-AGI % Inhibition 
20 µg/mL (IC50 µg /mL) 
3a 4.42±0.04 16.55±0.32 1.78±0.00 
3b 6.97±0.16 40.72±0.63 ND 
3c ND 11.19±2.21 0.31±0.00 
3d 1.61±0.04 19.80±1.11 90.31±0.00 (3.02) 
3e 5.88±0.57 14.32±1.90 8.65±0.35 
3f 26.96±0.41 97.65±0.16 (1.32) ND 
3g 46.06±1.10 97.32±0.00 (1.35) ND 
3h 11.33±0.24 31.99±0.32 1.59±0.26 
3i 6.94±0.93 31.88±0.47 4.35±0.17 
3j 31.34±0.73 93.96±0.32 (1.54) ND 
3k 1.18±0.00 17.79±1.42 ND 
3l 0.80±0.04 47.87±0.00 ND 
3m ND 51.90±1.27 ND 
3n 1.00±0.00 43.06±1.11 ND 
3o 4.59±0.93 26.17±0.32 ND 
3p 21.25±1.78 27.52±0.00 4.23±0.00 
3q ND 38.14±2.06 ND 
3r 0.20±0.00 24.05±0.16 ND 
3s 3.81±0.24 38.81±0.17 ND 
3t 5.88±0.08 28.86±0.32 ND 
3u 0.86±0.61 21.25±0.00 ND 
3v ND 26.73±1.11 ND 
3w 4.27±0.00 12.08±0.63 ND 
3x 5.65±0.16 30.31±0.79 ND 
3y 8.12±0.17 25.28±0.00 ND 
Ascorbic acid 84.08±0.12 − − 
Trolox − 98.88±0.00 (1.25) − 
Acarbose − − 91.17±0.00 (2.69) 
DPPH: 1,1-Diphenyl-2-picrylhydrazyl; ABTS: 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulphonic acid; 
AGI: α-glucosidase inhibition; ND-Not detected 
 




2H), 3.87 (s, 6H), 3.74 (s, 3H);
 13
C NMR (101 MHz, 
DMSO-d6): δ 163.13, 153.20, 151.20, 149.22, 145.48, 
141.04, 133.91, 130.73, 128.79, 124.53, 105.76, 79.66, 




benzohydrazide, 3d: Yield 89%. Colourless solid. 
m.p. 212-214°C. FT-IR (KBr): 3193, 3003, 1678, 
1567, 1505, 1416, 1374, 1306, 1235, 1143 cm
−1
; 
1H NMR (300 MHz, DMSO-d6): δ 12.05 (s, 1H), 8.87 
(s, 1H), 8.63 (d, J = 3.8 Hz, 1H), 8.51 (s, 1H), 8.16 (d, 
J = 7.7 Hz, 1H), 8.07-7.81 (m, 2H), 7.50 (dd, J = 7.4, 
4.9 Hz, 1H), 7.39 (t, J = 8.7 Hz, 2H); 
13
C NMR (75 
MHz, DMSO-d6): δ 165.94, 163.46, 162.65, 151.23, 
149.25, 145.62, 133.94, 130.94, 130.85, 130.68, 





isonicotinohydrazide, 3e: Yield 89%. Colourless solid. 
m.p. 232-234°C. FT-IR (KBr): 3183, 3001, 2846, 1682, 




H NMR (400 MHz, 
DMSO-d6): δ 12.24 (s, 1H), 8.89 (d, J = 1.7 Hz, 1H), 
8.85-8.70 (m, 2H), 8.70-8.57 (m, 1H), 8.53 (s, 1H), 8.17 
(ddd, J = 8.7, 5.2, 3.4 Hz, 1H), 7.98-7.70 (m, 2H), 7.50 
(dt, J = 33.0, 16.5 Hz, 1H);
 13
C NMR (101 MHz, 
DMSO-d6): δ 161.73, 150.97, 150.34, 148.89, 146.30, 





benzohydrazide, 3f: Yield 93%. Colourless solid. m.p. 
165-167°C. FT-IR (KBr): 3180, 3027, 1647, 1580, 




H NMR (400 MHz, 
DMSO-d6): δ 12.22 (s, 1H), 8.81 (s, 1H), 8.48 (d, J = 
2.9 Hz, 1H), 8.43-8.30 (m, 1H), 7.95 (d, J = 7.3 Hz, 
2H), 7.62 (d, J = 7.1 Hz, 1H), 7.55 (t, J = 6.7 Hz, 3H); 
13
C NMR (101 MHz, DMSO-d6): δ 163.70, 151.24, 
149.86, 142.93, 136.22, 133.43, 132.55, 129.11, 




methoxybenzohydrazide, 3g: Yield 89%. Colourless 
solid. m.p. 168-170°C. FT-IR (KBr): 3416, 3227, 3051, 




H NMR (400 
MHz, DMSO-d6): δ 12.10 (s, 1H), 8.78 (s, 1H), 8.47 (dd, 
J = 4.6, 1.9 Hz, 1H), 8.37 (d, J = 6.1 Hz, 1H), 7.94 (d,  
J = 8.7 Hz, 2H), 7.54 (dd, J = 7.7, 4.7 Hz, 1H), 7.08 (d,  
J = 8.8 Hz, 2H), 3.85 (s, 3H); 
13
C NMR (101 MHz, 
DMSO-d6): δ 163.08, 162.73, 151.09, 149.76, 142.13, 
136.13, 130.17, 129.23, 125.42, 124.29, 114.28, 55.95; 




trimethoxybenzohydrazide, 3h: Yield 91%, 
Colourless solid, m.p. 172-174°C. FT-IR (KBr): 3207, 





H NMR (300 MHz, DMSO-d6): δ 
12.10 (s, 1H), 8.79 (s, 1H), 8.52-8.45 (m, 1H), 8.39 
(d, J = 7.2 Hz, 1H), 7.56 (dd, J = 7.7, 4.7 Hz, 1H), 
7.27 (s, 2H), 3.88 (s, 6H), 3.74 (s, 3H); 
13
C NMR (75 
MHz, DMSO-d6): δ 163.19, 153.22, 151.23, 149.80, 
142.65, 141.28, 136.28, 129.13, 128.49, 124.32, 
105.85, 60.64, 56.64; ESI-MS: m/z 350 [M+H]+. 
(E)-N'-((2-Chloropyridin-3-yl)methylene)-4-
fluorobenzohydrazide, 3i: Yield 82%. Colourless 
solid. m.p. 179-181°C. FT-IR (KBr): 3186, 3037, 




H NMR (400 
MHz, DMSO-d6): δ 12.23 (s, 1H), 8.79 (s, 1H), 8.48 
(d, J = 2.9 Hz, 1H), 8.38 (d, J = 7.5 Hz, 1H), 8.10-
7.96 (m, 2H), 7.55 (dd, J = 7.5, 4.7 Hz, 1H), 7.40 (t, J 
= 8.7 Hz, 2H); 
13
C NMR (101 MHz, DMSO-d6): δ 
166.05, 163.56, 162.63, 151.27, 149.86, 143.02, 
136.22, 130.96, 129.90, 129.05, 124.30, 116.05; ESI-




yl)methylene)isonicotinohydrazide, 3j: Yield 88%. 
Colourless solid. m.p. 184-186°C. FT-IR (KBr): 3172, 
2990, 1681, 1555, 1405, 1286, 1149, 1060 cm
−1
; 
1H NMR (400 MHz, DMSO-d6): δ 12.41 (s, 1H), 8.82 
(d, J = 5.2 Hz, 3H), 8.50 (dd, J = 4.6, 1.9 Hz, 1H), 
8.39 (dd, J = 7.8, 1.9 Hz, 1H), 7.86 (dd, J = 4.5, 1.6 
Hz, 2H), 7.57 (dd, J = 7.7, 4.7 Hz, 1H); 
13
C NMR 
(101 MHz, DMSO-d6): δ 162.29, 151.55, 150.90, 
150.03, 144.23, 140.49, 136.38, 128.83, 124.38, 




yl)methylene)benzohydrazide, 3k: Yield 83%. 
Colourless solid. m.p. 243-245°C. FT-IR (KBr): 3208, 





H NMR (400 MHz, DMSO-d6): δ 11.95 
(s, 1H), 8.52 (s, 1H), 8.34-8.19 (m, 1H), 8.10 (d,  
J = 6.2 Hz, 1H), 7.91 (d, J = 7.2 Hz, 2H), 7.60 (d,  
J = 7.2 Hz, 1H), 7.54 (t, J = 7.3 Hz, 2H), 7.05 (dd,  
J = 7.5, 4.8 Hz, 1H), 3.23-2.77 (m, 4H), 1.70 (d,  
J = 3.5 Hz, 4H), 1.59-1.10 (m, 2H); 
13
C NMR (101 
MHz, DMSO-d6): δ 163.72, 162.13, 149.19, 145.25, 
135.58, 133.98, 132.25, 128.97, 128.14, 120.64, 





yl)methylene)benzohydrazide, 3l: Yield 92%, 
Colourless solid. m.p. 212-214°C. FT-IR (KBr): 3200, 
2934, 2831, 1634, 1431, 1372, 1260, 1176, 1063 
cm−1; 1H NMR (400 MHz, DMSO-d6): δ 11.83  




(s, 1H), 8.51 (s, 1H), 8.28 (dd, J = 4.7, 1.8 Hz, 1H), 
8.08 (d, J = 7.1 Hz, 1H), 7.91 (m, 2H), 7.05 (m, 3H), 
3.84 (s, 3H), 3.24-2.86 (m, 4H), 1.93-1.62 (m, 4H), 
1.63-1.43 (m, 2H); 
13
C NMR (101 MHz, DMSO-d6): 
δ 163.12, 162.50, 162.05 149.03, 144.63, 135.50, 
130.07, 125.96, 120.79, 118.09, 114.20, 55.93, 52.55, 





Yield 94%. Colourless solid. m.p. 224-226°C. FT-IR 





H NMR (400 MHz, DMSO-d6): δ 
11.81 (s, 1H), 8.53 (s, 1H), 8.29 (dd, J = 4.6, 1.7 Hz, 
1H), 8.09 (d, J = 6.4 Hz, 1H), 7.21 (s, 2H), 7.05 (dt,  
J = 16.6, 8.3 Hz, 1H), 3.87 (s, 6H), 3.74 (s, 3H), 3.22-
2.92 (m, 4H), 1.69 (d, J = 3.5 Hz, 4H), 1.59 (d,  
J = 4.7 Hz, 2H); 
13
C NMR (101 MHz, DMSO-d6): δ 
163.33, 162.20, 153.20, 149.18, 145.28, 140.98, 
135.68, 129.17, 120.61, 118.10, 105.83, 60.63, 56.65, 




yl)methylene)benzohydrazide, 3n: Yield 87%. 
Colourless solid. m.p. 232-234°C. FT-IR (KBr): 3217, 




H NMR (400 MHz, DMSO-d6): δ 11.96 (s, 1H), 8.51 
(s, 1H), 8.29 (dd, J = 4.6, 1.6 Hz, 1H), 8.18-8.03 (m, 
1H), 7.99 (dd, J = 8.5, 5.6 Hz, 2H), 7.39 (t, J = 8.8 Hz, 
2H), 7.05 (dd, J = 7.5, 4.8 Hz, 1H), 325-2.91, (m, 4H), 
1.70 (d, J = 3.4 Hz, 4H), 1.59 (d, J = 4.8 Hz, 2H); 
13
C NMR (101 MHz, DMSO-d6): δ 162.62, 162.14, 
149.22, 145.35, 135.58, 130.92, 130.83, 130.43, 130.72, 
120.58, 118.10, 116.32, 115.96, 52.57, 26.07, 24.39; 




isonicotinohydrazide, 3o: Yield 87%. Colourless 
solid. m.p. 242 244°C. FT-IR (KBr): 3193, 3062, 





H NMR (300 MHz, DMSO-d6): δ 12.17  
(s, 1H), 8.80 (dd, J = 4.5, 1.5 Hz, 2H), 8.53 (s, 1H), 
8.31 (dd, J = 4.7, 1.9 Hz, 1H), 8.11 (dd, J = 7.6, 1.8 
Hz, 1H), 7.83 (dd, J = 4.5, 1.5 Hz, 2H), 7.07 (dd,  
J = 7.6, 4.8 Hz, 1H), 3.11 (d, J = 5.3 Hz, 4H), 1.70  
(s, 4H), 1.59 (d, J = 4.1 Hz, 2H); 
13
C NMR (75 MHz, 
DMSO-d6): δ 162.34, 150.82, 149.49, 146.48, 141.04, 
135.74, 123.61, 122.06, 120.29, 118.12, 52.62, 26.07, 




benzohydrazide, 3p: Yield 85%. Colourless solid. 
m.p. 227-229°C. FT-IR (KBr): 3248, 2838, 1646, 




H NMR (400 
MHz, DMSO-d6): δ 11.93 (s, 1H), 8.56 (s, 1H), 8.33 
(dd, J = 4.6, 1.6 Hz, 1H), 8.14 (d, J = 6.3 Hz, 1H), 
7.91 (d, J = 7.2 Hz, 2H), 7.58 (dt, J = 26.9, 7.2 Hz, 
3H), 7.12 (dd, J = 7.5, 4.8 Hz, 1H), 3.82-3.76 (m, 
4H), 3.16- 3.09 (m, 4H); 
13
C NMR (101 MHz, 
DMSO-d6): δ 163.22, 160.62, 148.76, 144.38, 135.35, 
133.48, 131.75, 128.47, 127.62, 120.23, 118.22, 




yl)methylene)benzohydrazide, 3q: Yield 86%. 
Colourless solid. m.p. 201-203°C. FT-IR (KBr): 3265, 





(400 MHz, DMSO-d6): δ 11.81 (s, 1H), 8.55 (s, 1H), 
8.32 (dd, J = 4.7, 1.8 Hz, 1H), 8.11 (s, 1H), 7.96-7.81 
(m, 2H), 7.22-6.83 (m, 3H), 3.84 (s, 3H), 3.83-3.70 (m, 
4H), 3.23-2.91 (m, 4H); 
13
C NMR (101 MHz, DMSO-
d6): δ 163.10, 162.53, 161.08, 149.14, 144.21, 135.79, 
130.07, 125.95, 120.89, 118.77, 114.23, 66.69, 55.94, 




3-yl)methylene)benzohydrazide, 3r: Yield 84%. 
Colourless solid. m.p. 228-230°C. FT-IR (KBr): 3180, 




H NMR (400 MHz, DMSO-d6): δ 11.79 (s, 1H), 8.56 
(s, 1H), 8.33 (d, J = 3.3 Hz, 1H), 8.13 (d, J = 7.1 Hz, 
1H), 7.21 (s, 2H), 7.12 (d, J = 2.5 Hz, 1H), 3.87 (s, 
6H), 3.82-3.76 (m, 4H), 3.74 (s, 3H), 3.14 (s, 
4H);
13
C NMR (101 MHz, DMSO-d6): δ 163.37, 
161.11, 153.23, 149.27, 144.89, 141.02, 136.02, 
129.22, 120.74, 118.76, 105.85, 66.64, 60.64, 56.68, 




yl)methylene) benzohydrazide, 3s: Yield 82%. 
Colourless solid. m.p. 226-228°C. FT-IR (KBr): 3256, 





(300 MHz, DMSO-d6): δ 11.94 (s, 1H), 8.55 (s, 1H), 
8.33 (d, J = 4.8 Hz, 1H), 8.13 (d, J = 6.7 Hz, 1H), 
8.06-7.86 (m, 2H), 7.39 (t, J = 8.7 Hz, 2H), 7.12 (dd, 
J = 7.4, 4.9 Hz, 1H), 3.79 (d, J = 4.1 Hz, 4H), 3.13 (s, 
4H); 
13
C NMR (75 MHz, DMSO-d6): δ 162.63, 
161.15, 149.32, 144.98, 135.89, 130.91, 130.62, 
120.68, 118.76, 116.10, 115.89, 66.69, 51.77; ESI-
MS: m/z 329 [M+H]+. 
(E)-N'-((2-Morpholinopyridin-3-yl)methylene) 
isonicotinohydrazide, 3t: Yield81%. Colourless 
solid. m.p. 169-171°C. FT-IR (KBr): 3218, 3112, 




H NMR (400 
MHz, DMSO-d6): δ 12.12 (s, 1H), 8.81 (dd, J = 4.4, 
1.6 Hz, 2H), 8.57 (s, 1H), 8.34 (dd, J = 4.8, 1.9 Hz, 
1H), 8.14 (dd, J = 7.6, 1.8 Hz, 1H), 7.82 (dd, J = 4.4, 
1.6 Hz, 2H), 7.13 (dd, J = 7.6, 4.8 Hz, 1H), 3.91-3.54 




(m, 4H), 3.25-2.89 (m, 4H); 
13
C NMR (101 MHz, 
DMSO-d6): δ 162.17, 161.26, 150.86, 149.59, 146.12, 
141.02, 136.06, 122.04, 120.40, 118.79, 66.69, 51.80; 




yl)methylene) benzohydrazide, 3u: Yield 83%. 
Colourless solid. m.p. 223-225°C. FT-IR (KBr): 3209, 
3066, 2833, 1641, 1579, 1430, 1368, 1292, 1068 cm
−1
; 
1H NMR (400 MHz, DMSO-d6): δ 11.94 (s, 1H), 8.53 
(s, 1H), 8.39-8.24 (m, 1H), 8.14 (d, J = 7.5 Hz, 1H), 7.91 
(d, J = 7.2 Hz, 2H), 7.61 (d, J = 7.2 Hz, 1H), 7.55 (t, J = 
7.4 Hz, 2H), 7.12 (dd, J = 7.5, 4.8 Hz, 1H), 3.48-3.35 
(m, 4H), 2.83 (dd, J = 5.9, 3.6 Hz, 4H); 
13
C NMR (101 
MHz, DMSO-d6): δ 163.71, 162.00, 149.23, 144.82, 
135.84, 133.97, 132.29, 129.00, 128.12, 121.09, 118.81, 




yl)methylene)benzohydrazide, 3v: Yield 83%. 
Colourless solid. m.p. 231-233°C. FT-IR (KBr): 3186, 





H NMR (300 MHz, DMSO-d6): δ 11.82 (s, 
1H), 8.52 (s, 1H), 8.37-8.20 (m, 1H), 8.12 (d, J = 7.1 
Hz, 1H), 7.91 (d, J = 8.8 Hz, 2H),7.10 (t, J =9.9Hz, 
3H), 3.84 (s, 3H), 3.38 (m, 4H), 2.84 (m, 4H); 
13C NMR (75 MHz, DMSO-d6): δ 163.36, 162.54, 
161.93, 149.09, 144.19, 135.76, 130.06, 125.94, 





3-yl)methylene)benzohydrazide, 3w: Yield 91%. 
Colourless solid. m.p. 207-209°C. FT-IR (KBr): 3182, 





H NMR (300 MHz, DMSO-d6): δ 11.82 (s, 
1H), 8.53 (s, 1H), 8.32 (d, J = 3.0 Hz, 1H), 8.12 (d, J 
= 6.8 Hz, 1H), 7.21 (s, 2H), 7.12 (dd, J = 7.5, 4.8 Hz, 
1H), 3.87 (s, 6H), 3.74 (s, 3H), 3.41 (s, 4H),2.92-2.68 
(m, 4H); 
13
C NMR (75 MHz, DMSO-d6): δ 163.37, 
162.93, 153.22, 149.23, 144.84, 141.61, 135.97, 
129.23, 121.04, 118.80, 105.84, 60.64, 56.68, 53.79, 




yl)methylene)benzohydrazide, 3x: Yield92%. 
Colourless solid. m.p. 230-232°C. FT-IR (KBr): 3215, 




H NMR (300 MHz, DMSO-d6): δ 11.97  
(s, 1H), 8.52 (s, 1H), 8.37-8.22 (m, 1H), 8.21-8.04  
(m, 1H), 7.99 (dd, J = 8.6, 5.6 Hz, 2H), 7.40 (t, J = 
8.8 Hz, 2H), 7.12 (dd, J = 7.5, 4.8 Hz, 1H), 3.69-3.36 
(m, 4H), 2.83 (s, 4H); 
13
C NMR (75 MHz, DMSO-
d6): δ 162.61, 162.01, 149.28, 144.93, 135.86, 130.90, 
130.86, 121.03, 118.83, 116.11, 115.89, 53.83, 27.34; 




yl)methylene) isonicotinohydrazide, 3y: Yield 85%. 
Colourless solid. m.p. 256-258°C. FT-IR (KBr): 3191, 





H NMR (300 MHz, DMSO-d6): δ 12.15 
(s, 1H), 8.81 (dd, J = 4.5, 1.5 Hz, 2H), 8.54  
(s, 1H), 8.34 (dd, J = 4.7, 1.8 Hz, 1H), 8.14 (dd, J = 
7.6, 1.8 Hz, 1H), 7.82 (dd, J = 4.5, 1.5 Hz, 2H), 7.13 
(dd, J = 7.6, 4.8 Hz, 1H), 3.40 (dd, J = 6.0, 3.4 Hz, 
4H), 2.93-2.68 (m, 4H); 
13
C NMR (75 MHz, DMSO-
d6): δ 162.17 16212, 150.85, 149.54, 146.10, 141.01, 
136.02, 122.03, 120.73, 118.83, 53.86, 27.34; ESI-





The anti-bacterial activity of prepared compounds 
were evaluated against two Gram-positive organisms 
(Bacillus subtilis; Staphylococcus aureus) and two 
Gram-negative organisms (Pseudomonas aeruginosa, 
Escherichia coli) by agar well diffusion method by using 
streptomycin as standard
23
. The anti-fungal activity of 
the prepared compounds was evaluated against yeast 
(Candida albicans, MTCC 3017) and fluconazole was 
used as standard drug. 
 
Zone of inhibition plate tests 
Well plate method is followed for both the anti-
bacterial and anti-fungal activities for measuring the 
zone of inhibitions
25
. For anti-bacterial activity test 
strains used Gram positive and Gram negative in 
nutrient agar. For anti-fungal studies test strains used 
yeast and the medium used is potato dextrose agar. The 
synthesized compounds were used for activity studies 
and the concentration of each compound is  
1.0 mg/mL along with standard and control. The 
media, petri dishes were autoclaved at 121 ºC for  
15 min. After sterilization the plates were poured  
with appropriate medium left over for 30 min for 
solidification, later the plates were inoculated with  
60 µl of test inoculum using sterile cotton swabs. An 8 
mm width size wells were made with sterile cork borer 
and in each well exactly 100 µl of sample were loaded. 
Control and standard also placed in separate wells. The 
plates were initially incubated for 20-30 min at 4 ºC to 
allow the compounds to diffuse into the agar, and then 
subsequently incubated for 24 h at 37 ºC for bacteria 
and 48 h at 28 ºC for fungi. Zone diameters were 
expressed in mm using calibrated scale. Experiment 
was triplicate to minimize the deviations. 




Determination of MIC and MBC 
Minimum inhibition concentration (MIC) is the 
lowest concentration of an anti-microbial agent that 
will inhibit the visible growth of a microorganism. 
The MIC was determined using the tube dilution 
method. The compounds were dissolved in dimethyl 
sulfoxide (DMSO) at concentration of 0.500 mg /mL 
(stock solution). The compounds having better  
anti-microbial activity were selected for the MIC 
(minimum inhibitory concentration) and MBC 
(minimum bactericidal concentration) studies against 
all above microbial strains. The concentrations of test 
samples were serially diluted from 500 to 1.9µg/mL 
and one tube without drug serves as control. All the 
tubes were inoculated with 1 mL of respective 
cultures having an OD of 0.2 (~ McFarland standard) 
and the tubes were incubated at 37 ºC for 16 h. The 
turbidity of each tube is measured with respect to control 
tube. MIC values are defined as the lowest concentration 
of compound at which growth is completely inhibited. 
After incubation the culture from each tube was  
spread on nutrient agar plates to evaluate the MBC 
concentration. The concentration at which the cells are 
completely dead was defined as MBC. 
 
DPPH scavenging activity 
Assay for the scavenging of stable free radical 
based on DPPH [1,1-diphenyl-2-picrylhydrazyl] was 
done as reported earlier was performed
25
. Briefly, in a 
96-well micro plate, 25 µL of test sample dissolved in 
DMSO (1 mg/mL), 125 µL of 0.1 M tris-HCl buffer 
(pH 7.4) and 125 µL of 0.5 mM DPPH solution 
dissolved in absolute ethyl alcohol were added.  
The reaction mixture was shaken well and incubated 
in dark condition for 30 min and read at 517 nm 
spectrophotometrically (Spectra Max plus384, 
Molecular Devices Corporation, Sunnyvale, CA, 
USA). Percentage of DPPH scavenging was 
calculated as (1-B/ A) x 100 where ‘A’ represents 
absorbance of control without test samples and ‘B’ 




free radical scavenging assay 
Scavenging of the ABTS
+
 [2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid)] was 
performed as described by Walker and Everette  
with suitable modifications
26
. Briefly, 100 mL stock 
solution of ABTS
+
 (0.5 mM) was prepared by 
addition of 1 mL potassium persulfate (6.89 mM PBS, 
pH 8.0). The mixture was stored in the dark for 16 h. 
Test compounds were dissolved in DMSO (5mg/mL). 
Primary screening was done by mixing 10 µL of test 
compound in 100 µL of methanol followed by 190 µL 
of ABTS
+
 in a 96-well microplate. Absorbance  
of decolorized ABTS
+
 was measured at 734 nm after 
15 min incubation in the dark on a BioTek 
synergy4 
multi-mode microplate reader. For each test sample a 
separate blank sample (devoid of ABTS
+
) was used 
for background subtraction. The percentage of ABTS
+
 
scavenging was calculated applying following formula: 
% ABTS
+
 scavenging = [(Absorbancecontrol-
Absorbancetest)/Absorbancecontrol ×100]. 
Various serial dilutions of active compounds were 
prepared and tested for determination of SC50 values. 




α-Glucosidase inhibitory activity was determined 
as per earlier reported method
26
. Rat intestinal acetone 
powder in normal saline (100:1; w/v) was sonicated 
properly and the supernatant was used as a source  
of crude intestinal α-glucosidase after centrifugation. 
In brief, 20 µL of test samples (5 mg/mL DMSO 
solution) were reconstituted in 100 µL of 100 mM-
phosphate buffer (pH 6.8) in 96-well microplate  
and incubated with 50 µL of crude intestinal α-
glucosidase for 5 min before 50 µL substrate (5 mM, 
p-nitrophenyl- α-D-glucopyranoside prepared in same 
buffer) was added. Release of p-nitrophenol was 
measured at 405 nm spectrophotometrically (Spectra 
Max plus 384), Molecular Devices Corporation, 
Sunnyvale, CA, USA) 5 min after incubation with 
substrate. Individual blanks for test samples were 
prepared to correct background absorbance where 
substrate was replaced with 50 µL of buffer. Control 
sample contained 10 µL DMSO in place of test 
samples. Percentage of enzyme inhibition was 
calculated as (1-B/A) × 100 where ‘A’ represents 
absorbance of control without test samples and ‘B’ 
represents absorbance in presence of test samples.  
For calculation of 50% enzyme inhibitory activity 
(IC50%) more than five dilutions of primary 
screening concentration (5 mg/mL DMSO solution) 
of test compounds were prepared. The IC50 values 




In conclusion, series of N'-(pyridin-3-ylmethylene) 
benzohydrazides 3a-y have been prepared by the 
condensation of nicotinaldehydes 1a-e with 




benzohydrazides 2a-e in the presence of glacial AcOH 
in ethanol at RT. Compounds were evaluated for anti-
microbial, free radical scavenging (DPPH, ABTS
.+
) 
and α-glucosidase inhibitory activities. Compound 3h 
identified as anti-fungal agent. Compounds 3f-g and 
3j identified as potent ABTS
.+
 free radical scavenging 
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